Biosimilars
🇪🇺 EMA Page 2EMA news and analysis for pharmaceutical BD, investment, and market access · 5 articles on this page
Track global biosimilar approvals, market entry strategies, and regulatory pathways. Gain critical intelligence for your pharmaceutical BD and investment decisions.
Showing 13–17 of 17 articles
Cigna Healthcare Adds Accord BioPharma's IMULDOSA Biosimilar to Preferred Coverage Plans
EU Pharmaceutical Legislation Reform: Impact on Generic and Biosimilar Markets 2026-27
EMA Biosimilar Policy: Market Impact and Regulatory Insights 2024
EMA Decision on Biosimilar Pricing: Key Insights for Oncology Market
Denosumab Biosimilar Authorization by EMA: Key Details